Where We Are

From September of 2007, mPedigree will be based out of the Ghanaian capital, Accra. Plans are for rapid expansion across Africa in the next few years. Progress so far has been hugely encouraging, with current plans for a second nation-wide technology trial slated for Q4, 2008.

Date	Scheduled Task	Completed
2006	Concept research and development.
Q1, Q2 2007	Survey of funding sources and actualization plan development. Patent application filing.
Aug 2007	Funding acquisition and implementation rollout planning.
Sept 2007	Project initiation in Ghana, West Africa. Provision of coded scratch-off labels to drug manufacturing implementation partner.
Nov 2007	Acquisition of reverse-billed 1393 shortcode on all Ghanaian cellular networks.
Dec 2007	Complete survey of developing nation drug manufacturer and supply chain agent anti-counterfeit needs concluded. Technology design updated.
Jan 2008	Initial technology trial and client intercept anti-counterfeit survey.
Mar 2008	Production of new fake drug documentary, If Symptoms Persist. Social marketing campaign partnerships secured.
April 2008	Launch and national telecast of If Symptoms Persist and associated news and radio appearances. World IP Day press conference with the Food and Drugs Board (regulators) regarding counterfeit product awareness.
June 2008	Organization of Inaugural Health Stakeholders Symposium themed "Innovation for Health Governance" as part of three-pronged stakeholder integration strategy.
July 2008	Collaboration with Ghana Food and Drugs Board on inaugural National Dialogue on Counterfeiting. Technology Transformation Seminar featuring public discussion on mPedigree Technology. MPedigree formally joins the business coalition against counterfeiting and illicit trade (CACIT).
Q4 2008	Large scale technology trial in Ghana with increased number of manufacturers and wholesalers. Publication of mPedigree client-intercept survey results in key public health journal. Evaluation of expansion to Nigerian market.
Q1 2009	Additional social marketing campaign partnerships secured. Increased law-enforcement patronage.
Q2 2009	Implementation in Nigerian market for anti-malarials and antibiotics.
2012	West African critical drug supply chain secured via stepped up regulation and increased collaboration between law enforcement and civilian citizenry. This will be achieved via low cost fake drug detection technology specifically built with low-resourced areas in mind.